Cargando…

Key Features in the Design and Function of Nanocarriers for Intranasal Administration of Gene Therapy in Huntington Disease

A major obstacle to fulfilling the therapeutic promise of gene therapies for hereditary brain diseases, such as Huntington’ Disease (HD), is the requirement for viral vectors and/or an invasive delivery system (stereotaxic injection into brain or infusion into the intrathecal space). HD is an autoso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fihurka, Oksana, Aradi, Stephen, Sava, Vasyl, Sanchez-Ramos, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514752/ https://www.ncbi.nlm.nih.gov/pubmed/37744989 http://dx.doi.org/10.33696/nanotechnol.4.043

Ejemplares similares

Data on enrichment of chitosan nanoparticles for intranasal delivery of oligonucleotides to the brain
por: Sava, Vasyl, et al.
Publicado: (2020)

Measurement of Δ(9)THC and metabolites in the brain and peripheral tissues after intranasal instillation of a nanoformulation
por: Upadhyay, Gunjan, et al.
Publicado: (2023)

Curcumin and Quercetin-Loaded Lipid Nanocarriers: Development of Omega-3 Mucoadhesive Nanoemulsions for Intranasal Administration
por: Vaz, Gustavo Richter, et al.
Publicado: (2022)

Design and Efficacy of Nanogels Formulations for Intranasal Administration
por: Aderibigbe, Blessing A., et al.
Publicado: (2018)

Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
por: Fihurka, Oksana, et al.
Publicado: (2023)

Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery
por: Maher, Rebecca, et al.
Publicado: (2023)

Predicting Severity of Huntington's Disease With Wearable Sensors
por: Scheid, Brittany H., et al.
Publicado: (2022)

The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC
por: Fihurka, Oksana, et al.
Publicado: (2022)

Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation
por: González-Fernández, Felipe M., et al.
Publicado: (2021)

Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease
por: García-Muñoz, Rafael A., et al.
Publicado: (2022)

Intranasal administration of acetylcholinesterase inhibitors
por: Costantino, Henry R, et al.
Publicado: (2008)

Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration
por: de Barros, Cecília, et al.
Publicado: (2021)

Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice
por: Yin, Dong Xu, et al.
Publicado: (2022)

Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease
por: Yu-Taeger, Libo, et al.
Publicado: (2019)

A drug-specific nanocarrier design for efficient anticancer therapy
por: Shi, Changying, et al.
Publicado: (2015)

Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration
por: Sipos, Bence, et al.
Publicado: (2020)

Intranasal Administration of Mammary Tumour Milk Factor
por: Begg, A. M.
Publicado: (1949)

Inadequate quality of administration of intranasal corticosteroid sprays
por: Rollema, Corine, et al.
Publicado: (2019)

Pharmacokinetics of Nanosomal Form of Levodopa in Intranasal Administration
por: Nedorubov, Andrey Anatolievich, et al.
Publicado: (2019)

Intranasal Administration for Pain: Oxytocin and Other Polypeptides
por: Bharadwaj, Vimala N., et al.
Publicado: (2021)

Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes
por: Vasilieva, Elmira A., et al.
Publicado: (2022)

Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal
por: Teaima, Mahmoud H., et al.
Publicado: (2022)

Rational Design of Thermosensitive Hydrogel to Deliver Nanocrystals with Intranasal Administration for Brain Targeting in Parkinson's Disease
por: Tan, Yun, et al.
Publicado: (2021)

Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media
por: Jamshidnejad-Tosaramandani, Tahereh, et al.
Publicado: (2023)

Effects of an Inhibitor of Monocyte Recruitment on Recovery from Traumatic Brain Injury in Mice Treated with Granulocyte Colony-Stimulating Factor
por: Song, Shijie, et al.
Publicado: (2017)

Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
por: Rook, Morgan E., et al.
Publicado: (2022)

Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease
por: Wang, Kaixuan, et al.
Publicado: (2021)

Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy
por: Mao, Xiaoman, et al.
Publicado: (2022)

Targeting glioblastoma via intranasal administration of Ff bacteriophages
por: Dor-On, Eyal, et al.
Publicado: (2015)

Efficacy of intranasal administration of artesunate in experimental cerebral malaria
por: Marijon, Anne, et al.
Publicado: (2014)

Anxiolytic Action of Taurine via Intranasal Administration in Mice
por: Jung, Jung Hwa, et al.
Publicado: (2019)

Intranasal administration of dantrolene increased brain concentration and duration
por: Wang, Jintao, et al.
Publicado: (2020)

Essential Oil-Loaded NLC for Potential Intranasal Administration
por: Bonaccorso, Angela, et al.
Publicado: (2021)

Evaluation of the techniques and steps of intranasal corticosteroid sprays administration
por: Rattanawong, Supachet, et al.
Publicado: (2022)

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
por: Jin, Zhiyu, et al.
Publicado: (2022)

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
por: Pfiffner, Miriam, et al.
Publicado: (2023)

Intranasal Esketamine administration in catatonia: a case report.
por: Romay, J., et al.
Publicado: (2023)

Neurotherapeutic potential of intranasal administration of human breast milk
por: Malhotra, Atul
Publicado: (2023)

Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge
por: Areny-Balagueró, Aina, et al.
Publicado: (2022)

Combined Dextran-Graft-Polyacrylamide/Zinc Oxide Nanocarrier for Effective Anticancer Therapy in vitro
por: Chumachenko, Vasyl, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9c0jhcd3abi8ntlk12v74qr5vv